Business Wire

Xilam: Record 2017 Annual Results

Jaa

Regulatory News:

The Board of Directors of Xilam Animation S.A. (Paris:XIL) convened on 27 March 2018. The meeting, chaired by Marc du Pontavice, was held to review the consolidated financial statements as at 31 December 2017.

Consolidated income statement (in thousands of euros)   2017(1)   2017 restated(2)   2016   % chg.
New productions(3)   15,319       10,756   +42%
Catalogue   9,017       5,083   +77%
Other   62       39   +59%
Revenue   24,398       15,878   +54%
Other current operating income   2,174       1,263   +72%
Total operating income   26,572       17,141   +55%
Operating expenses   (18,940)       (12,851)   +47%
Other non-current operating income and (expenses)   -       16    
Operating income   7,632   8,663   4,306   +77%
Current operating margin   31.3%   35.5%   27.1%    
Net income   5,948   6,739   3,198   +86%
Net margin   24.4%   27.6%   20.1%    
(1) Audit underway        
(2) Operating income and net income restated for the impact of the bonus share award plans
(3) Including subsidies and development

Increased activity reveals the quality of the business model

Growing demand for Xilam’s new productions is a clear testament to the Group’s positioning. 2017 was a turning point in terms of the increased impact of Xilam’s business model.

Four factors are behind the sharp increase in income:

  • business activity that is growing more quickly than the cost structure;
  • increased value of new productions pre-sales is making a greater contribution to income;
  • the expansion of the catalogue is mitigating the pace at which series are amortised;
  • Xilam’s investment strategy allows it to retain almost 100% of the revenue from its productions.

This virtuous set-up demonstrates the strength of Xilam’s business model, which is beginning to have an impact on the Group’s financial results.

Xilam’s operating margin increased 77% to a record high of EUR 7.632 million, or 31.3% of revenues.

This published operating income figure includes the impact of the two bonus share award plans set up in 2016 and 2017, a portion of which has been provisioned in the year’s operating expenses.

Restated for the accounting impact of the expense associated with these two share plans and the related social security charges, operating income for 2017 would have totalled EUR 8.663 million, for an operating margin of 35.5%.

The Group’s net margin came out to 24.4%, with net income totalling EUR 5.948 million, an 86% increase on 2016.
The income tax expense of EUR 1.950 million includes a deferred tax expense in the amount of EUR 1.163 million, with no impact on cash assets.
Restated net income includes the restatement of the expense associated with the bonus share award plans and the related tax assets, and totalled EUR 6.739 million.

Global demand rising sharply

Xilam posted a 54% increase in revenue compared to last year, driven by substantial growth in New Productions and Catalogue revenue.

The Group benefits from a favourable price effect on both New Productions (+42% in value terms, +24% in volume) and the Catalogue segment (+77%). This is primarily due to increased competition between traditional (free or pay) television channels and digital platforms. Digital platforms now account for 23% of total revenue (compared to barely 8% three years ago) and 40% of Catalogue revenue.

The 21% increase in the number of video views on YouTube, the world’s leading video streaming platform, to 2.6 billion in 2017, is clear evidence of the global demand for the Group’s content.

Powerful drivers that will support our growth

With a solid structure and a production team that is appropriately sized to satisfy the demand from television channels and digital platforms, Xilam is ready to move to the next level.

As such, seven different shows are currently in production:

  • The fifth season of Oggy and the Cockroaches , which has been pre-purchased by Gulli in France and Cartoon Network internationally. With this new production, the Oggy brand will boast a total of 117 half-hour programmes produced in Ultra HD, thereby guaranteeing the brand’s global sustainability for several years to come. Deliveries will be completed in 2018.
  • The studio's first pre-school show, Paprika , an original new series pre-purchased by France Télévisions in France and by Disney abroad, with delivery to be completed in the first half of 2018.
  • The second season of Magic, bought by Gulli on the heels of a successful first season, with delivery to be completed in the first half of 2018.
  • Mr Magoo, adapted from the famous American series from the 1950s and 60s, went into production in early 2017, following the purchase of rights by France Télévisions and Cartoon Network for deliveries in 2018.
  • If I were an animal , a wildlife series designed especially for children, went into production in late 2016, following the purchase of rights by France Télévisions and Netflix for deliveries to be completed during the first quarter of 2018.
  • Coach me if you can , an original, football-themed creation from the Xilam studio that is expected to be released worldwide and will be launched to coincide with Euro 2020.
  • Season 3 of Zig & Sharko , which has already been pre-purchased by clients that subscribed to the previous seasons.

These series will enable Xilam to achieve its target of delivering 70 half-hour programmes in 2018, thereby confirming the solid progress of its operations. Xilam’s four studios (Paris, Lyon, Angoulême and Ho-Chi-Minh City) are now fully operational and well prepared to meet this target.

Other projects created in the Xilam studios will enter production in 2018. In particular, these include The Fabulous Adventures of Prince Moka and Tiny Bad Wolf , two original creations that will afford Xilam additional growth avenues in the coming years.

The Group is also continuing with its strategy of developing its catalogue income through merchandising revenues, drawing on the set-up of an agent network covering 75% of the world.

Chairman and CEO of Xilam, Marc du Pontavice, commented, “We are proud and delighted to be able to present these record results to our shareholders and investors. The relevance of the strategy adopted by Xilam for more than 15 years was confirmed in 2017, as was the virtuous circle achieved through original creations, management of the value chain and formats adapted to international markets and the digital sector.
Xilam’s unique positioning is the result of several long years of development, construction and investment.
With a stronger, more structured organisation and a buoyant economic backdrop, Xilam is now benefiting from all of its assets in order to continue its solid trend of growth and profitability.”

About Xilam

Xilam is one of Europe’s leading animation companies, creating, producing and distributing original children’s and family entertainment content across TV, film and digital media platforms.

Founded in 1995 by Marc du Pontavice, Xilam owns a catalogue of more than 2,000 animated episodes and three feature films including strong brands such as Oggy & the Cockroaches, Zig & Sharko, The Daltons and its first pre-school series, Paprika.

Broadcast in over 190 countries on all the major TV networks and digital platforms, in particular garnering over 2.6 billion views on YouTube in 2017, Xilam’s programme catalogue makes the company one of the top global content providers in animation.

Xilam employs more than 400 people, including 300 artists, who are based across its four studios located in Paris, Lyon, Angoulême and Ho-Chi-Minh City in Vietnam.

Xilam is listed on Compartment B of Euronext Paris
PEA-eligible
SRD long-eligible
ISIN code: FR0004034072 / Ticker: XIL

Contact information

Xilam
Marc du Pontavice – Chairman and CEO
François Bardoux – CFO
Tel: +33 1 40 18 72 00

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

SmartStream Steps Ahead with New Industry Digital Payments Solution23.10.2018 02:01Tiedote

SmartStream Technologies, the financial Transaction Lifecycle Management (TLM®) solutions provider, today announced the launch of TLM Aurora, the next generation of Corona, the industry’s leading reconciliation platform – the first new module is designed to support the new industry standards in the digital payments world, by providing connectors to SWIFT GPI, RTGS, as well as Blockchain based networks, allowing for real-time operational control, proactive exception management and low TCO. TLM Aurora provides the new generation of integrated operational control for the digital marketplace. As transactions increase in variability, velocity and volume, the need for scalable, real-time, integrated reconciliations is greater than ever. TLM Aurora supports organisations in performing operations such as SWIFT and SEPA transfers, mobile, cash and card payments, digital currencies, settlements and reconciliations. The solution is agile enough to support the smallest of organisations and can be

CoreLogic to Acquire Symbility Solutions Inc.23.10.2018 01:12Tiedote

CoreLogic (NYSE: CLGX), a leading global provider of property information, insight, analytics and data-enabled solutions, today announced the Company has entered into a definitive agreement to acquire the outstanding shares of Symbililty Solutions Inc. (“Symbility”) (TSX.V: SY) not already owned by CoreLogic. CoreLogic currently holds approximately a 28% ownership interest in Symbility. Symbility, founded in 2004, is a leading provider of subscription and cloud-based property insurance claims workflow solutions for the Property & Casualty insurance industry. Symbility also provides an extensive array of innovative enterprise mobile and application software solutions. The company is headquartered in Toronto, Canada and operates in the U.S., Canada, the United Kingdom, Germany, Netherlands, Australia and New Zealand. “Symbility expands our footprint in property and casualty insurance domestically and in key markets around the globe. Further scaling our insurance and international footpri

Pacific Drilling Awarded Contract for the Pacific Bora23.10.2018 00:00Tiedote

Pacific Drilling S.A. (OTC: PACDQ) (“Pacific Drilling” or the “Company”) announced today that its deepwater drillship the Pacific Bora has been awarded a contract by Nigerian Agip Exploration Limited (a subsidiary of Eni SpA) for drilling operations in Nigeria. The term of the contract is for one firm well plus two additional option wells. The contract is expected to commence in mid to late November 2018 and firm contract backlog is estimated at $9 million. Pacific Drilling Chief Executive Officer Paul Reese commented: “On the heels of our previous announcement of new work for Pacific Santa Ana in Mauritania, we are pleased to have secured this contract for the Bora which reflects our substantial experience in Nigeria and our uninterrupted commitment to providing exceptional drilling services to our clients.” Currently offshore Abidjan, Côte d'Ivoire, the Pacific Bora is a sixth generation deepwater, dynamically-positioned drillship capable of operating in water depths up to 10,000 fee

ResMed Wins German Patent Infringement Case Against Fisher & Paykel22.10.2018 23:30Tiedote

ResMed (NYSE: RMD) (ASX: RMD), the world’s leading tech-driven medical company and innovator in sleep apnea and respiratory care, today announced the results of a court and patent office ruling in Germany in ResMed’s favor. A trial court ruling from the Munich District Court states that the headgear used on two Fisher & Paykel CPAP masks – the Simplus full face and Eson 2 nasal mask – infringes ResMed patent EP 2 373 368 B1 in Germany. In a separate decision, the Opposition Division of the European Patent Office had already decided that the patent asserted against Fisher & Paykel is valid. Each decision may be appealed by Fisher & Paykel. “We applaud the Munich District Court for reaching this just finding, and are exploring all options in light of the fact that Fisher & Paykel is selling CPAP masks with headgear that infringes a valid ResMed patent in Germany,” said ResMed Chief Administrative Officer and Global General Counsel David Pendarvis. “We will continue to defend our intellec

Grand Prize Winner in $1.75M Water Abundance XPRIZE Announced at XPRIZE Visioneering 201822.10.2018 20:49Tiedote

During Visioneering 2018, XPRIZE’s annual gathering of philanthropists and innovators to evaluate concepts for future competitions, the Foundation revealed the results of its latest, completed XPRIZE. The Skysource / Skywater Alliance was announced as the grand prize winner of the $1.75M Water Abundance XPRIZE, a two-year competition aimed at alleviating the global water crisis with energy-efficient technologies that harvest fresh water from thin air. In addition at Visioneering, five new prize concepts were evaluated with top honors going to a prize concept called “Coral Survival”, a prize designed to protect and restore coral reefs. This prize will move forward into the XPRIZE pipeline. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181022005795/en/ The Skysource / Skywater Alliance team, based in Venice Beach, California, wins the Water Abundance XPRIZE (Photo: Business Wire) The Water Abundance XPRIZE, powered by the Tat

Positive Trial Results with Filgotinib in Psoriatic Arthritis and Ankylosing Spondylitis Both Published in The Lancet22.10.2018 20:15Tiedote

Gilead Sciences, Inc. (Nasdaq: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced that detailed results from two clinical trials evaluating filgotinib, an investigational, selective JAK1 inhibitor, for the treatment of psoriatic arthritis and ankylosing spondylitis were both published in The Lancet. The publication of the Phase 2 EQUATOR data also coincides with a plenary session presentation at the 2018 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting. “The results of the EQUATOR and TORTUGA studies demonstrate that filgotinib improved the signs and symptoms of patients with psoriatic arthritis whose disease had not responded to prior therapies and independently, for those with ankylosing spondylitis,” said John McHutchison, AO, MD, Chief Scientific Officer and Head of Research and Development, Gilead Sciences. “These findings represent an important step forward in our efforts to improve outcomes for people livin

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme